cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Arcellx Inc
2 own
2 watching
Current Price
$58.07
$-2.1
(-3.49%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
2,990.38M
52-Week High
52-Week High
75.10000
52-Week Low
52-Week Low
28.03000
Average Volume
Average Volume
0.49M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization2,990.38M
icon52-Week High75.10000
icon52-Week Low28.03000
iconAverage Volume0.49M
iconDividend Yield--
iconP/E Ratio--
What does the Arcellx Inc do?
Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company s lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It is also developing ACLX-001, an immunotherapeutic combination composed of ARC-T cells and bi-valent SparX proteins targeting BCMA to treat r/r MM; ACLX-002 and ACLX-003 for treating r/r acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS); and other AML/MDS product candidates, as well as solid tumor programs. The company was formerly known as Encarta Therapeutics, Inc. and changed its name to Arcellx, Inc. in January 2016. Arcellx, Inc. was incorporated in 2014 and is headquartered in Gaithersburg, Maryland.
Read More
How much money does Arcellx Inc make?
News & Events about Arcellx Inc.
Globe Newswire
9 months ago
NEW YORK, July 01, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Arcellx, Inc. ( Arcellx or the Company ) (NASDAQ: ACLX). Such investors are advised to...
Globe Newswire
9 months ago
NEW YORK, June 25, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Arcellx, Inc. (Arcellx or the Company) (NASDAQ:ACLX). Such investors are advised to contact Robert S. Willoughby atnewaction@pomlaw.com or 888-476-6529, ext. 7980. The investigation concerns ...
PR Newswire
9 months ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arcellx, Inc. - ACLX SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arcellx, Inc. - ACLX PR Newswire NEW YORK, June 23, 2023 NEW YORK, June 23, 2023 /PRNewswire/ -- Pomerantz LLP...
TipRanks Financial Blog
9 months ago
Theres a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on BridgeBio Pharma (BBIO Research Report) and Arcell... Theres a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on BridgeBio Pharma (BBIO Research Report) and Arcellx...
PR Newswire
9 months ago
Thinking about trading options or stock in Dice Therapeutics, Arcellx, Coherent, US Foods Holding, or Microsoft? Thinking about trading options or stock in Dice Therapeutics, Arcellx, Coherent, US Foods Holding, or Microsoft? PR Newswire NEW YORK, June 20, 2023 NEW YORK, June 20, 2023 /PRNewswire...
Frequently Asked Questions
Frequently Asked Questions
What is Arcellx Inc share price today?
plus_minus_icon
Can Indians buy Arcellx Inc shares?
plus_minus_icon
How can I buy Arcellx Inc shares from India?
plus_minus_icon
Can Fractional shares of Arcellx Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Arcellx Inc stocks?
plus_minus_icon
What is today’s traded volume of Arcellx Inc?
plus_minus_icon
What is today’s market capitalisation of Arcellx Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Arcellx Inc?
plus_minus_icon
What percentage is Arcellx Inc down from its 52-Week High?
plus_minus_icon
What percentage is Arcellx Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$58.07
$-2.1
(-3.49%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00